Cargando…

Can Studying Genetically Predisposed Individuals Inform Prevention Strategies for RA?

Rheumatoid arthritis (RA) is a prevalent autoimmune disorder in which complex genetic predisposition interacts with multiple environmental factors to precipitate chronic and progressive immune-mediated joint inflammation. Currently, in most affected individuals, ongoing suppression of the inflammati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fowler-Woods, Amanda, Smolik, Irene, Anaparti, Vidyanand, O’Neil, Liam, El-Gabalawy, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544392/
https://www.ncbi.nlm.nih.gov/pubmed/34682981
http://dx.doi.org/10.3390/healthcare9101301
_version_ 1784589807723216896
author Fowler-Woods, Amanda
Smolik, Irene
Anaparti, Vidyanand
O’Neil, Liam
El-Gabalawy, Hani
author_facet Fowler-Woods, Amanda
Smolik, Irene
Anaparti, Vidyanand
O’Neil, Liam
El-Gabalawy, Hani
author_sort Fowler-Woods, Amanda
collection PubMed
description Rheumatoid arthritis (RA) is a prevalent autoimmune disorder in which complex genetic predisposition interacts with multiple environmental factors to precipitate chronic and progressive immune-mediated joint inflammation. Currently, in most affected individuals, ongoing suppression of the inflammation is required to prevent irreversible damage and functional loss. The delineation of a protracted preclinical period in which autoimmunity is initially established and then evolves to become pathogenic provides unprecedented opportunities for interventions that have the potential to prevent the onset of this lifelong disease. Clinical trials aimed at assessing the impact of specific prevention strategies require the identification of individuals who are at high risk of future RA development. Currently, these risk factors include a strong family history of RA, and the detection of circulating RA-associated autoantibodies, particularly anti-citrullinated protein antibodies (ACPA). Yet, even in such individuals, there remains considerable uncertainty about the likelihood and the timeframe for future disease development. Thus, individuals who are approached to participate in such clinical trials are left weighing the risks and benefits of the prevention measures, while having large gaps in our current understanding. To address this challenge, we have undertaken longitudinal studies of the family members of Indigenous North American RA patients, this population being known to have a high prevalence of RA, early age of onset, and familial clustering of cases. Our studies have indicated that the concepts of “risk” and “prevention” need to be communicated in a culturally relevant manner, and proposed prevention interventions need to have an appropriate balance of effectiveness, safety, convenience, and cultural acceptability. We have focused our proposed prevention studies on immunomodulatory/anti-inflammatory nutritional supplements that appear to strike such a complex balance.
format Online
Article
Text
id pubmed-8544392
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85443922021-10-26 Can Studying Genetically Predisposed Individuals Inform Prevention Strategies for RA? Fowler-Woods, Amanda Smolik, Irene Anaparti, Vidyanand O’Neil, Liam El-Gabalawy, Hani Healthcare (Basel) Communication Rheumatoid arthritis (RA) is a prevalent autoimmune disorder in which complex genetic predisposition interacts with multiple environmental factors to precipitate chronic and progressive immune-mediated joint inflammation. Currently, in most affected individuals, ongoing suppression of the inflammation is required to prevent irreversible damage and functional loss. The delineation of a protracted preclinical period in which autoimmunity is initially established and then evolves to become pathogenic provides unprecedented opportunities for interventions that have the potential to prevent the onset of this lifelong disease. Clinical trials aimed at assessing the impact of specific prevention strategies require the identification of individuals who are at high risk of future RA development. Currently, these risk factors include a strong family history of RA, and the detection of circulating RA-associated autoantibodies, particularly anti-citrullinated protein antibodies (ACPA). Yet, even in such individuals, there remains considerable uncertainty about the likelihood and the timeframe for future disease development. Thus, individuals who are approached to participate in such clinical trials are left weighing the risks and benefits of the prevention measures, while having large gaps in our current understanding. To address this challenge, we have undertaken longitudinal studies of the family members of Indigenous North American RA patients, this population being known to have a high prevalence of RA, early age of onset, and familial clustering of cases. Our studies have indicated that the concepts of “risk” and “prevention” need to be communicated in a culturally relevant manner, and proposed prevention interventions need to have an appropriate balance of effectiveness, safety, convenience, and cultural acceptability. We have focused our proposed prevention studies on immunomodulatory/anti-inflammatory nutritional supplements that appear to strike such a complex balance. MDPI 2021-09-29 /pmc/articles/PMC8544392/ /pubmed/34682981 http://dx.doi.org/10.3390/healthcare9101301 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Fowler-Woods, Amanda
Smolik, Irene
Anaparti, Vidyanand
O’Neil, Liam
El-Gabalawy, Hani
Can Studying Genetically Predisposed Individuals Inform Prevention Strategies for RA?
title Can Studying Genetically Predisposed Individuals Inform Prevention Strategies for RA?
title_full Can Studying Genetically Predisposed Individuals Inform Prevention Strategies for RA?
title_fullStr Can Studying Genetically Predisposed Individuals Inform Prevention Strategies for RA?
title_full_unstemmed Can Studying Genetically Predisposed Individuals Inform Prevention Strategies for RA?
title_short Can Studying Genetically Predisposed Individuals Inform Prevention Strategies for RA?
title_sort can studying genetically predisposed individuals inform prevention strategies for ra?
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544392/
https://www.ncbi.nlm.nih.gov/pubmed/34682981
http://dx.doi.org/10.3390/healthcare9101301
work_keys_str_mv AT fowlerwoodsamanda canstudyinggeneticallypredisposedindividualsinformpreventionstrategiesforra
AT smolikirene canstudyinggeneticallypredisposedindividualsinformpreventionstrategiesforra
AT anapartividyanand canstudyinggeneticallypredisposedindividualsinformpreventionstrategiesforra
AT oneilliam canstudyinggeneticallypredisposedindividualsinformpreventionstrategiesforra
AT elgabalawyhani canstudyinggeneticallypredisposedindividualsinformpreventionstrategiesforra